Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Dental Bone Graft Substitute Market, 2025 - Increasing Demand from Customers and Rising Inclination Toward Cosmetic Dentistry


DUBLIN, Sept. 25, 2020 /PRNewswire/ -- The "Dental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton), End User (Hospital) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global dental bone graft substitutes market is projected to reach USD 839.5 million by 2025 from USD 548.6 million in 2020, at a CAGR of 8.9% from 2020 to 2025.

The global dental bone graft substitute market is projected to grow at a CAGR of 7.9% during the forecast period

Factors such as the technological advancements in the market are propelling the growth of the dental bone graft substitutes market. Additionally, rising inclination towards cosmetic dentistry, increasing demand from customers and growing industry standards are spurring the growth of the global dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries are hampering the growth of this market.

The recent COVID-19 global pandemic has also impacted the dental bone graft substitute market. Demand from the main end-users has declined significantly as key regions and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.

The synthetic bone graft segment to witness the highest growth rate in the OTC orthopedic braces and supports market, by product, during the forecast period

The synthetic bone graft segment is expected to witness the highest growth rate during the forecast period. The high growth in this segment can be attributed to the several benefits offered by these products, such as the benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease to get transferred. Because of these benefits, a synthetic bone graft is the fastest-growing type in the dental bone graft substitutes market.

The socket preservative segment accounted for the largest share of the dental bone graft substitute market, by application, in 2019.

The socket preservation segment accounted for the largest share of the dental bone graft substitute industry in 2019. Nowadays, there is a rise in awareness of oral care, and people are inclining more towards preventive measures rather than that of curative treatment, which helps socket preservation procedure to hold the largest share in the overall market.

The Bio OSS segment accounted for the largest share of the dental bone graft substitute, by distribution product, in 2019

Growing adoption of Bio Oss among medical professionals is due to benefits such as high implant survival rates and comparable with implants placed in the pristine bone, Also, it is easy to use and used in various applications such as high implant survival rates, comparable with implants placed in pristine bone in extraction sockets, horizontal augmentation, peri-implant defects, periodontal regeneration, ridge augmentation, sinus floor elevation, and vertical augmentation. Furthermore, increasing the availability of clinical data for the safety and efficacy of Bio Oss products will drive market growth.

The Asia Pacific market to grow at the highest CAGR during the forecast period.

The dental bone graft substitutes market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period majorly due to the rising geriatric population and medical tourism in countries such as India and China offer significant growth opportunities as they are increasingly attracting patients (for dental treatments) from developed countries, as treatments in these countries are more affordable as compared to developed markets in North America and Europe.

Market Dynamics

Drivers

Restraints

Opportunities

Challenges

Effects of Covid-19

Pricing Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/9kqdn1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: